Previous 10 | Next 10 |
Vaccinex (VCNX) announces results from the its CLASSICAL-Lung clinical trial in the journal Clinical Cancer Research.The Phase 1b/2 trial evaluated pepinemab, in combination with the immune checkpoint inhibitor Bavencio (avelumab) for the treatment of non-small cell lung cancer ((NSCLC))...
ROCHESTER, N.Y., April 21, 2021 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced the publication of results from t...
Vaccinex (VCNX): FY Revenue of $0.63M (+21.2% Y/Y) beats by $0.02M.Cash and cash equivalents and marketable securities of $10.6MShares +8.15% PM.Press Release For further details see: Vaccinex beats on revenue
Reported top-line results from Phase 2 SIGNAL study that indicates potential cognitive benefit of pepinemab in neurodegenerative disease. New Alzheimer’s study expected to begin enrollment in Q2 Phase 1/2 study to evaluate pepinemab in combination with KEYTRUDA® in a...
Entera Bio Ltd. (ENTX +51% following osteoporosis drug results.ContraFect Corporation (CFRX +35% on receiving $86.8M in BARDA contract.GigaMedia Limited (GIGM) +34%.Seelos Therapeutics (SEEL +30% as BTIG initiates with street high target.Fujian Blue Hat Interacti...
ROCHESTER, N.Y., March 11, 2021 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced that Dr. Maurice Zauderer, chief ...
Today, we take our first in-depth look at small cap developmental firm Vaccinex since April of last year. The company has signed a couple of interesting deals over the past weeks that merited a reassessment. An updated investment thesis on Vaccinex follows below. For further...
IT Tech Packaging (ITP) -23% on stock offering.Ping Identity Holding (PING) -14% on Q4 results.ReTo Eco-Solutions (RETO) -10%.United States Antimony (UAMY) -9%.BioCryst Pharmaceuticals (BCRX) -9% on Q4 earnings.Best Buy (BBY) -7% on Q4 results.Chimerix (CMRX) -7% on Q...
4 Biotech Penny Stocks to Watch Right Now Over the past twelve months, interest in biotech penny stocks has continued to see new peaks. While this is partly due to the pandemic’s effects, it seems that it goes beyond this. Due to Covid, a massive influx of capital has come in...
Gainers: Vascular Biogenics (VBLT) +22%, Sunesis Pharmaceuticals (SNSS) +21%, Savara (SVRA) +8%, Pandion Therapeutics (PAND) +5%.Losers: PAVmed (PAVM) -17%, Isoray (ISR) -16%, Vaccinex (VCNX) -16%, Onconova Therapeutics (ONTX) -15%, elect...
News, Short Squeeze, Breakout and More Instantly...
Company expects to lock database in June and remains on track to report key outcomes later in July. Pepinemab targets astrocyte reactivity and neuroinflammation, believed to be key drivers of neurodegeneration. ROCHESTER, N.Y., June 06, 2024 (GLOBE NEWSWIRE) -- Vaccinex, I...
A look at the top 10 most actives in the United States Novo Integrated Sciences Inc. (NVOS) rose 132.8% to $1.05 on volume of 308,155,573 shares Greenwave Technology Solutions Inc. (GWAV) fell 7.9% to $0.0387 on volume of 278,348,616 shares Faraday Future Intelligent Electric Inc. (FFIE) ...
Vaccinex, Inc. (NASDAQ: VCNX) is one of today's top gainers. The company's shares have moved 15.16% on the day to $6. Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet...